Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 39, 2011, Pages 16259-16264

  Zhang, Cen ^a   Lin, Meihua ^a   Wu, Rui ^a   Wang, Xiaowen ^a   Yang, Bo ^b   Levine, Arnold J ^a,c   Hu, Wenwei ^a   Feng, Zhaohui ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c INSTITUTE FOR ADVANCED STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; PARKIN; PROTEIN P53;

ANIMAL CELL CULTURE; ANTIOXIDANT ACTIVITY; ARTICLE; CARCINOGENESIS; GAMMA IRRADIATION; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL CULTURE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE; WARBURG EFFECT;

ANIMALS; ENERGY METABOLISM; GENES, TUMOR SUPPRESSOR; GLUCOSE; HUMANS; MICE; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

MUS;

EID: 80053635472     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1113884108     Document Type: Article

References (34)

1. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324:1029-1033.
2. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11:85-95.
3. Warburg O (1956) On the origin of cancer cells. Science 123:309-314.
4. Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis,mitochondrial physiology, and tumor maintenance. Cancer Cell 9:425-434. (Pubitemid 43832190)
5. Christofk HR, et al. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230-233. (Pubitemid 351380249)
6. Vousden KH, Prives C (2009) Blinded by the light: The growing complexity of p53. Cell 137:413-431.
7. Levine AJ, Hu W, Feng Z (2006) The P53 pathway: What questions remain to be explored? Cell Death Differ 13:1027-1036.
8. Vousden KH, Ryan KM (2009) p53 and metabolism. Nat Rev Cancer 9:691-700.
9. Bensaad K, et al. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107-120. (Pubitemid 44040989)
10. Matoba S, et al. (2006) p53 regulates mitochondrial respiration. Science 312: 1650-1653. (Pubitemid 43902663)
11. Hu W, et al. (2010) Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA 107:7455-7460.
12. Suzuki S, et al. (2010) Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci USA 107:7461-7466.
13. Sablina AA, et al. (2005) The antioxidant function of the p53 tumor suppressor. Nat Med 11:1306-1313. (Pubitemid 41752911)
14. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM (2004) Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304:596-600. (Pubitemid 38541920)
15. Yoon KA, Nakamura Y, Arakawa H (2004) Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet 49:134-140. (Pubitemid 38506727)
16. Palacino JJ, et al. (2004) Mitochondrial dysfunction and oxidative damage in parkindeficient mice. J Biol Chem 279:18614-18622. (Pubitemid 38623283)
17. Pesah Y, et al. (2004) Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131:2183-2194. (Pubitemid 38702049)
18. Veeriah S, et al. (2010) Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet 42:77-82.
19. Cesari R, et al. (2003) Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci USA 100:5956-5961. (Pubitemid 36581860)
20. Letessier A, et al. (2007) Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene 26: 298-307. (Pubitemid 46095741)
21. Poulogiannis G, et al. (2010) PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc Natl Acad Sci USA 107:15145-15150.
22. Fujiwara M, et al. (2008) Parkin as a tumor suppressor gene for hepatocellular carcinoma. Oncogene 27:6002-6011.
23. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B (1992) Definition of a consensus binding site for p53. Nat Genet 1:45-49.
24. Hoh J, et al. (2002) The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci USA 99:8467-8472. (Pubitemid 34693586)
25. Hu W, Feng Z, Teresky AK, Levine AJ (2007) p53 regulates maternal reproduction through LIF. Nature 450:721-724. (Pubitemid 350207678)
26. Feng Z, Zhang H, Levine AJ, Jin S (2005) The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102:8204-8209. (Pubitemid 40800067)
27. Vassilev LT, et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303:844-848. (Pubitemid 38174664)
28. Goldberg MS, et al. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278:43628-43635. (Pubitemid 37345989)
29. da Costa CA, et al. (2009) Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat Cell Biol 11:1370-1375.
30. Geisler S, et al. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12:119-131.
31. Deng H, Dodson MW, Huang H, Guo M (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA 105:14503-14508.
32. Suen DF, Narendra DP, Tanaka A, Manfredi G, Youle RJ (2010) Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells. Proc Natl Acad Sci USA 107:11835-11840.
33. Raver-Shapira N, et al. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26:731-743. (Pubitemid 46856247)
34. Koivisto UM, et al. (1991) Differential regulation of the GLUT-1 and GLUT-4 glucose transport systems by glucose and insulin in L6 muscle cells in culture. J Biol Chem 266:2615-2621.